| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17742700P | 2000-01-21 | 2000-01-21 | |
| US177427P | 2000-01-21 | ||
| US728859 | 2000-11-30 | ||
| US09/728,859US6599284B2 (en) | 2000-01-21 | 2000-11-30 | Osmotic device having a preformed passageway that increases in size |
| PCT/US2001/000582WO2001052819A1 (en) | 2000-01-21 | 2001-01-08 | Osmotic device having a preformed passageway that increases in size |
| Publication Number | Publication Date |
|---|---|
| EP1248598A1 EP1248598A1 (en) | 2002-10-16 |
| EP1248598A4true EP1248598A4 (en) | 2004-01-21 |
| EP1248598B1 EP1248598B1 (en) | 2006-12-13 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP01901878AExpired - LifetimeEP1248598B1 (en) | 2000-01-21 | 2001-01-08 | Osmotic device having a preformed passageway that increases in size |
| Country | Link |
|---|---|
| US (1) | US6599284B2 (en) |
| EP (1) | EP1248598B1 (en) |
| AR (1) | AR026148A1 (en) |
| AT (1) | ATE347881T1 (en) |
| AU (1) | AU2001227732A1 (en) |
| BR (1) | BRPI0107761B8 (en) |
| CA (1) | CA2395981C (en) |
| DE (1) | DE60125142T2 (en) |
| DK (1) | DK1248598T3 (en) |
| ES (1) | ES2277909T3 (en) |
| MX (1) | MXPA02007017A (en) |
| PT (1) | PT1248598E (en) |
| UY (1) | UY26546A1 (en) |
| WO (1) | WO2001052819A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020131908A1 (en)* | 2000-01-13 | 2002-09-19 | George Benda | Selective release apparatus for fluids |
| BRPI0206432A2 (en)* | 2001-01-12 | 2016-10-25 | Sun Pharmaceutical Ind Ltd | methods for administering two or more active therapeutic agents and for treating diabetes mellitus or symptoms associated with diabetes mellitus in a human and spaced drug release system |
| KR200249057Y1 (en)* | 2001-03-22 | 2001-10-19 | 김진환 | Sewage backflow integrated into the lid and base. Odor Prevention Device |
| RU2324475C2 (en)* | 2001-04-10 | 2008-05-20 | Сан Фармасьютикал Индастриз Лимитед | Composition released in pulse mode at preset time |
| JP4307995B2 (en)* | 2001-07-12 | 2009-08-05 | ギブン イメージング リミテッド | Device for examining the body lumen |
| US7585283B2 (en)* | 2001-07-12 | 2009-09-08 | Given Imaging Ltd. | Device and method for examining a body lumen |
| TW200302748A (en)* | 2002-02-01 | 2003-08-16 | Pfizer Prod Inc | Osmotic delivery system |
| GB0203296D0 (en)* | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
| ITMI20020515A1 (en)* | 2002-03-12 | 2003-09-12 | Jagotec Ag | SYSTEM FOR THE CONTROLLED RELEASE OF ONE OR MORE ACTIVE INGREDIENTS |
| ITMI20020514A1 (en)* | 2002-03-12 | 2003-09-12 | Jagotec Ag | THERAPEUTIC SYSTEM FOR THE CONTROLLED RELEASE OF ONE OR MORE ACTIVE PRINCIPLES |
| US8523788B2 (en)* | 2002-07-11 | 2013-09-03 | Given Imaging Ltd. | Device, system and method for examining a body lumen |
| US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
| US20050208132A1 (en)* | 2002-07-29 | 2005-09-22 | Gayatri Sathyan | Methods and dosage forms for reducing side effects of benzisozazole derivatives |
| US7785627B2 (en)* | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US9060941B2 (en)* | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US8084058B2 (en) | 2002-09-20 | 2011-12-27 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US7959946B2 (en)* | 2002-09-20 | 2011-06-14 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US8293799B2 (en)* | 2003-12-29 | 2012-10-23 | Osmotica Keresleedelmo és Szolgáltató KFT | Osmotic device containing a venlafaxine salt and a salt having an ion in common |
| US20060210633A1 (en)* | 2003-04-03 | 2006-09-21 | Sun Pharmaceutical Industries Limited | Programmed drug delivery system |
| KR101192722B1 (en) | 2003-04-24 | 2012-10-18 | 자고텍 아게 | Delayed release tablet with defined core geometry |
| WO2004093850A1 (en)* | 2003-04-24 | 2004-11-04 | Jagotec Ag | Tablet with coloured core |
| US8029822B2 (en)* | 2003-05-22 | 2011-10-04 | Osmotica Kereskedelmi és Seolgáltató KFT | Rupturing controlled release device having a preformed passageway |
| UY28326A1 (en)* | 2003-05-22 | 2004-06-30 | Osmotica Argentina S A | BREAKDOWN DEVICE CONTROLLED WITH A PREFORMED PASSAGE |
| US20060177507A1 (en)* | 2003-05-22 | 2006-08-10 | Joaquina Faour | Controlled release device containing lercanidipine |
| JP2007503389A (en)* | 2003-08-22 | 2007-02-22 | アルザ・コーポレーシヨン | Staged delivery of topiramate over long periods of time |
| US7611728B2 (en)* | 2003-09-05 | 2009-11-03 | Supernus Pharmaceuticals, Inc. | Osmotic delivery of therapeutic compounds by solubility enhancement |
| DE10351448A1 (en)* | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Flavor-containing drug formulations with improved pharmaceutical properties |
| CA2549195A1 (en)* | 2003-12-09 | 2005-06-23 | Spherics, Inc. | Bioadhesive polymers with catechol functionality |
| SE0401031D0 (en)* | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
| US8252331B2 (en)* | 2004-12-03 | 2012-08-28 | Osmotica Kereskedelmi és Szolgáltató, KFT | Osmotic device containing amantadine and an osmotic salt |
| US8574626B2 (en) | 2004-12-03 | 2013-11-05 | Osmotica Kereskedelmi és Szolgáltató KFT | Osmotic device containing amantadine and an osmotic salt |
| AR053986A1 (en) | 2004-12-03 | 2007-05-30 | Osmotica Pharmaceutical Argent | OSMOTIC DEVICE CONTAINING AMANTADINE AND AN OSMOTIC SALT |
| US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
| US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
| US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
| JP2008539047A (en) | 2005-04-28 | 2008-11-13 | プロテウス バイオメディカル インコーポレイテッド | Pharma Informatics System |
| US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
| EP2502621A1 (en)* | 2005-06-27 | 2012-09-26 | Valeant International (Barbados) SRL | Crystalline forms of bupropion HBr |
| KR20080030637A (en)* | 2005-06-29 | 2008-04-04 | 알자 코포레이션 | Semipermeable compositions provide reduced drying time for osmotic dosage forms |
| EP3367386A1 (en) | 2006-05-02 | 2018-08-29 | Proteus Digital Health, Inc. | Patient customized therapeutic regimens |
| US7772390B1 (en) | 2006-07-18 | 2010-08-10 | The Regents Of The University Of California | Lipid mediated nucleic acid synthesis |
| MX2009001248A (en) | 2006-08-03 | 2009-02-11 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid disease. |
| US8945005B2 (en) | 2006-10-25 | 2015-02-03 | Proteus Digital Health, Inc. | Controlled activation ingestible identifier |
| EP2069004A4 (en) | 2006-11-20 | 2014-07-09 | Proteus Digital Health Inc | Active signal processing personal health signal receivers |
| CA2676407A1 (en) | 2007-02-01 | 2008-08-07 | Proteus Biomedical, Inc. | Ingestible event marker systems |
| EP3236524A1 (en) | 2007-02-14 | 2017-10-25 | Proteus Digital Health, Inc. | In-body power source having high surface area electrode |
| WO2008112577A1 (en) | 2007-03-09 | 2008-09-18 | Proteus Biomedical, Inc. | In-body device having a multi-directional transmitter |
| WO2008112578A1 (en) | 2007-03-09 | 2008-09-18 | Proteus Biomedical, Inc. | In-body device having a deployable antenna |
| US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
| GB0711979D0 (en)* | 2007-06-21 | 2007-08-01 | Swelltec Ltd | Method and apparatus |
| BRPI0812918A2 (en)* | 2007-06-21 | 2014-12-09 | Swelltec Ltd | APPLIANCE AND METHOD WITH HYDROCARBILITY AND WATER DILATABLE BODY |
| US20090004281A1 (en)* | 2007-06-26 | 2009-01-01 | Biovail Laboratories International S.R.L. | Multiparticulate osmotic delivery system |
| US8637080B2 (en)* | 2007-06-28 | 2014-01-28 | Osmotica Kereskedelmi és Szolgáltató, KFT | Rupturing controlled release device comprising a subcoat |
| FI2192946T3 (en) | 2007-09-25 | 2022-11-30 | In-body device with virtual dipole signal amplification | |
| JP2011513865A (en) | 2008-03-05 | 2011-04-28 | プロテウス バイオメディカル インコーポレイテッド | Multi-mode communication ingestible event marker and system and method of using the same |
| US20090312627A1 (en)* | 2008-06-16 | 2009-12-17 | Matott Laura A | Radio-labeled ingestible capsule |
| EP2313002B1 (en) | 2008-07-08 | 2018-08-29 | Proteus Digital Health, Inc. | Ingestible event marker data framework |
| WO2010015840A1 (en)* | 2008-08-08 | 2010-02-11 | Cipla Limited | Osmotic delivery device with modified release |
| JP5715564B2 (en) | 2008-08-13 | 2015-05-07 | プロテウス デジタル ヘルス， インコーポレイテッド | Ingestible device and method of producing the same |
| US20100068254A1 (en)* | 2008-09-16 | 2010-03-18 | Mahalaxmi Gita Bangera | Modifying a medicament availability state of a final dosage form |
| US20100069821A1 (en)* | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex vivo modifiable medicament release-sites final dosage form |
| US20100068266A1 (en)* | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex vivo-modifiable multiple-release state final dosage form |
| US20100068153A1 (en)* | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex vivo activatable final dosage form |
| US20100068233A1 (en)* | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Modifiable dosage form |
| US20100068152A1 (en)* | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex vivo modifiable particle or polymeric based final dosage form |
| US20100069887A1 (en)* | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Multiple chamber ex vivo adjustable-release final dosage form |
| US20100068235A1 (en)* | 2008-09-16 | 2010-03-18 | Searete LLC, a limited liability corporation of Deleware | Individualizable dosage form |
| US20100068275A1 (en)* | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Personalizable dosage form |
| JP5785097B2 (en) | 2009-01-06 | 2015-09-24 | プロテウス デジタル ヘルス， インコーポレイテッド | Pharmaceutical dosage delivery system |
| SG196787A1 (en) | 2009-01-06 | 2014-02-13 | Proteus Digital Health Inc | Ingestion-related biofeedback and personalized medical therapy method and system |
| EP2391369A1 (en)* | 2009-01-26 | 2011-12-07 | Nitec Pharma AG | Delayed-release glucocorticoid treatment of asthma |
| NZ582836A (en)* | 2009-01-30 | 2011-06-30 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage |
| GB2480965B (en) | 2009-03-25 | 2014-10-08 | Proteus Digital Health Inc | Probablistic pharmacokinetic and pharmacodynamic modeling |
| KR101677698B1 (en) | 2009-04-28 | 2016-11-21 | 프로테우스 디지털 헬스, 인코포레이티드 | Highly reliable ingestible event markers and methods for using the same |
| US9149423B2 (en)* | 2009-05-12 | 2015-10-06 | Proteus Digital Health, Inc. | Ingestible event markers comprising an ingestible component |
| TWI517050B (en) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | System for supply chain management |
| WO2011079050A2 (en) | 2009-12-23 | 2011-06-30 | The Smart Pill Corporation | Method of evaluating constipation using an ingestible capsule |
| KR20170121299A (en) | 2010-04-07 | 2017-11-01 | 프로테우스 디지털 헬스, 인코포레이티드 | Miniature ingestible device |
| TWI557672B (en) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device |
| WO2012071280A2 (en) | 2010-11-22 | 2012-05-31 | Proteus Biomedical, Inc. | Ingestible device with pharmaceutical product |
| WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
| US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
| JP6144678B2 (en) | 2011-07-21 | 2017-06-07 | プロテウス デジタル ヘルス， インコーポレイテッド | Mobile communication device, system, and method |
| US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
| CN104487347B (en) | 2012-07-23 | 2017-09-01 | 普罗秋斯数字健康公司 | Method and system for manufacturing the tablet for including electronic device |
| CN102871982B (en)* | 2012-10-16 | 2014-09-10 | 中国科学院上海药物研究所 | Medicine osmotic pump preparation |
| MY168018A (en) | 2012-10-18 | 2018-10-11 | Proteus Biomedical Inc | Apparatus, system , and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device |
| US11149123B2 (en) | 2013-01-29 | 2021-10-19 | Otsuka Pharmaceutical Co., Ltd. | Highly-swellable polymeric films and compositions comprising the same |
| US10175376B2 (en) | 2013-03-15 | 2019-01-08 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
| EP3005281A4 (en) | 2013-06-04 | 2017-06-28 | Proteus Digital Health, Inc. | System, apparatus and methods for data collection and assessing outcomes |
| US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
| JP6392355B2 (en)* | 2013-09-13 | 2018-09-19 | アール．ピー．シェーラー テクノロジーズ、エルエルシー | Pellet-containing tablets |
| US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
| US20150306230A1 (en)* | 2014-04-28 | 2015-10-29 | Celanese Acetate Llc | Drug delivery vehicles comprising cellulose derivatives, starch derivatives, and combinations thereof |
| WO2016132220A1 (en) | 2015-02-20 | 2016-08-25 | Osmotica Kereskedelmi Es Szolgaltato Kft | Controlled release oral dosage form of gaba receptor agonist |
| US10987328B2 (en) | 2015-02-20 | 2021-04-27 | Osmotica Kereskedelmi Es Szolgaltato Kft | Controlled release dosage form |
| US10172800B2 (en) | 2015-02-20 | 2019-01-08 | Osmotica Kereskedelmi Es Szolgaltato Kft | Controlled release dosage form with enhanced pharmacokinetics |
| US10300032B2 (en) | 2015-02-20 | 2019-05-28 | Osmotica Kereskedelmi Es Szolgaltato Kft | Controlled release dosage form |
| US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
| US10187121B2 (en) | 2016-07-22 | 2019-01-22 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
| IL265827B2 (en) | 2016-10-26 | 2023-03-01 | Proteus Digital Health Inc | Methods for manufacturing capsules with ingestible event markers |
| US20190247331A1 (en) | 2018-02-15 | 2019-08-15 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság | Composition and method for treating neurological disease |
| US10213393B1 (en) | 2018-02-15 | 2019-02-26 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság | Composition and method for treating neurological disease |
| US10213394B1 (en) | 2018-02-15 | 2019-02-26 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság | Composition and method for treating neurological disease |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4595583A (en)* | 1984-03-19 | 1986-06-17 | Alza Corporation | Delivery system controlled administration of beneficial agent to ruminants |
| US5324280A (en)* | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
| US5558879A (en)* | 1995-04-28 | 1996-09-24 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
| US5681584A (en)* | 1993-04-23 | 1997-10-28 | Ciba-Geigy Corporation | Controlled release drug delivery device |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3916899A (en)* | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4285987A (en)* | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
| US4455143A (en)* | 1982-03-22 | 1984-06-19 | Alza Corporation | Osmotic device for dispensing two different medications |
| US4449983A (en)* | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
| US4765989A (en)* | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US5082668A (en)* | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
| US4615698A (en)* | 1984-03-23 | 1986-10-07 | Alza Corporation | Total agent osmotic delivery system |
| US4627851A (en)* | 1984-10-26 | 1986-12-09 | Alza Corporation | Colonic-therapeutic delivery system |
| US4685918A (en)* | 1985-02-01 | 1987-08-11 | Merck & Co., Inc. | Lipid osmotic pump |
| US4693886A (en)* | 1985-04-22 | 1987-09-15 | Alza Corporation | Osmotic device with inert core |
| US4857330A (en)* | 1986-04-17 | 1989-08-15 | Alza Corporation | Chlorpheniramine therapy |
| US4960416A (en)* | 1986-04-30 | 1990-10-02 | Alza Corporation | Dosage form with improved delivery capability |
| US4743248A (en)* | 1986-08-11 | 1988-05-10 | Alza Corporation | Dosage form for delivering acid sensitive beneficial agent |
| US5108756A (en)* | 1989-01-12 | 1992-04-28 | Pfizer Inc. | Dispensing devices powered by lyotropic liquid crystals |
| ES2077023T3 (en)* | 1989-03-10 | 1995-11-16 | Yamanouchi Pharma Co Ltd | COATING MATERIAL THAT CONTROLS THE RELEASE OF A MEDICINAL PRODUCT FOR FORMULATIONS OF PROLONGED ACTIVITY. |
| US5776493A (en)* | 1989-07-14 | 1998-07-07 | Alza Corporation | Oral osmotic device for delivery of nystatin with hydrogel driving member |
| US5273752A (en) | 1989-07-18 | 1993-12-28 | Alza Corporation | Controlled release dispenser comprising beneficial agent |
| US5200197A (en)* | 1989-11-16 | 1993-04-06 | Alza Corporation | Contraceptive pill |
| US5178866A (en)* | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
| US5221536A (en)* | 1990-05-07 | 1993-06-22 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
| US5057321A (en)* | 1990-06-13 | 1991-10-15 | Alza Corporation | Dosage form comprising drug and maltodextrin |
| US5240713A (en) | 1991-09-27 | 1993-08-31 | Alza Corporation | Dual rate agent delivery device |
| US5266332A (en)* | 1991-12-06 | 1993-11-30 | Alza Corporation | Method for administering anti-Parkinson drug |
| US5200195A (en)* | 1991-12-06 | 1993-04-06 | Alza Corporation | Process for improving dosage form delivery kinetics |
| US5914131A (en)* | 1994-07-07 | 1999-06-22 | Alza Corporation | Hydromorphone therapy |
| FR2723536A1 (en)* | 1994-08-11 | 1996-02-16 | Seth Pawan | COMPOSITION FOR SELECTIVE RELEASE OF AN ACTIVE INGREDIENT |
| US5718700A (en)* | 1994-09-20 | 1998-02-17 | Alza Corporation | Exit means in dosage form |
| CA2261787C (en)* | 1997-05-30 | 2006-11-14 | Laboratorios Phoenix U.S.A., Inc. | Multi-layered osmotic device |
| US6514530B2 (en)* | 1997-09-09 | 2003-02-04 | Alza Corporation | Dosage form comprising means for changing drug delivery shape |
| PT1140012E (en)* | 1998-12-17 | 2004-05-31 | Alza Corp | CONVERSATION OF FULL GELATINE CAPSULES WITH LIQUID IN LIBERTACAO SYSTEMS CONTROLLED BY MULTIPLE LAYERS |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4595583A (en)* | 1984-03-19 | 1986-06-17 | Alza Corporation | Delivery system controlled administration of beneficial agent to ruminants |
| US5324280A (en)* | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
| US5681584A (en)* | 1993-04-23 | 1997-10-28 | Ciba-Geigy Corporation | Controlled release drug delivery device |
| US5558879A (en)* | 1995-04-28 | 1996-09-24 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
| Publication number | Publication date |
|---|---|
| EP1248598B1 (en) | 2006-12-13 |
| AU2001227732A1 (en) | 2001-07-31 |
| DE60125142T2 (en) | 2007-10-25 |
| CA2395981A1 (en) | 2001-07-26 |
| MXPA02007017A (en) | 2004-03-10 |
| BRPI0107761A (en) | 2002-11-12 |
| UY26546A1 (en) | 2001-10-25 |
| DE60125142D1 (en) | 2007-01-25 |
| WO2001052819A1 (en) | 2001-07-26 |
| CA2395981C (en) | 2008-07-08 |
| BRPI0107761B8 (en) | 2021-07-06 |
| ATE347881T1 (en) | 2007-01-15 |
| AR026148A1 (en) | 2003-01-29 |
| PT1248598E (en) | 2007-03-30 |
| US20020099361A1 (en) | 2002-07-25 |
| ES2277909T3 (en) | 2007-08-01 |
| EP1248598A1 (en) | 2002-10-16 |
| DK1248598T3 (en) | 2007-03-05 |
| BRPI0107761B1 (en) | 2012-12-11 |
| US6599284B2 (en) | 2003-07-29 |
| Publication | Publication Date | Title |
|---|---|---|
| EP1248598A4 (en) | Osmotic device having a preformed passageway that increases in size | |
| EP1246613A4 (en) | Osmotic device within an osmotic device | |
| HK1091860A1 (en) | A device | |
| GB2369270B (en) | Cross-charging in a mobile-telecommunication network | |
| GB2367781B (en) | A Fence System | |
| HK1051309A1 (en) | A drinking device. | |
| AU145583S (en) | A gaming device | |
| IL156418A0 (en) | A delivery device | |
| AU145581S (en) | A gaming device | |
| GB0020622D0 (en) | A device | |
| HUP0201441A2 (en) | Device in a valve | |
| AU145578S (en) | A gaming device | |
| AU145577S (en) | A gaming device | |
| GB0119767D0 (en) | A fragmentising device | |
| GB0004771D0 (en) | A novelty device | |
| GB2366450B (en) | A re-armable tripping device | |
| GB0018998D0 (en) | A device | |
| ZA200106749B (en) | A ball. | |
| GB2402438B (en) | A dispensing device | |
| ZA200103441B (en) | Device for securing a sealing member in a predetermined position. | |
| GB0215069D0 (en) | A punching device | |
| GB0002149D0 (en) | Flow improvement element in a flow directing means | |
| ZA200208769B (en) | A device. | |
| GB0012431D0 (en) | A dispensing device | |
| GB0409012D0 (en) | Object retention in a rotable carousel |
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase | Free format text:ORIGINAL CODE: 0009012 | |
| 17P | Request for examination filed | Effective date:20020711 | |
| AK | Designated contracting states | Kind code of ref document:A1 Designated state(s):AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR | |
| AX | Request for extension of the european patent | Free format text:AL;LT;LV;MK;RO;SI | |
| A4 | Supplementary search report drawn up and despatched | Effective date:20031211 | |
| RA4 | Supplementary search report drawn up and despatched (corrected) | Effective date:20031211 | |
| RIC1 | Information provided on ipc code assigned before grant | Ipc:7A 61K 31/4422 B Ipc:7A 61K 9/00 B Ipc:7A 61K 9/22 A | |
| GRAP | Despatch of communication of intention to grant a patent | Free format text:ORIGINAL CODE: EPIDOSNIGR1 | |
| GRAS | Grant fee paid | Free format text:ORIGINAL CODE: EPIDOSNIGR3 | |
| GRAA | (expected) grant | Free format text:ORIGINAL CODE: 0009210 | |
| AK | Designated contracting states | Kind code of ref document:B1 Designated state(s):AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR | |
| REG | Reference to a national code | Ref country code:GB Ref legal event code:FG4D | |
| REG | Reference to a national code | Ref country code:CH Ref legal event code:EP | |
| REG | Reference to a national code | Ref country code:IE Ref legal event code:FG4D | |
| REF | Corresponds to: | Ref document number:60125142 Country of ref document:DE Date of ref document:20070125 Kind code of ref document:P | |
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] | Ref country code:MC Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date:20070131 | |
| REG | Reference to a national code | Ref country code:DK Ref legal event code:T3 | |
| REG | Reference to a national code | Ref country code:PT Ref legal event code:SC4A Free format text:AVAILABILITY OF NATIONAL TRANSLATION Effective date:20070227 | |
| REG | Reference to a national code | Ref country code:SE Ref legal event code:TRGR | |
| REG | Reference to a national code | Ref country code:CH Ref legal event code:NV Representative=s name:A. BRAUN, BRAUN, HERITIER, ESCHMANN AG PATENTANWAE | |
| ET | Fr: translation filed | ||
| REG | Reference to a national code | Ref country code:ES Ref legal event code:FG2A Ref document number:2277909 Country of ref document:ES Kind code of ref document:T3 | |
| PLBE | No opposition filed within time limit | Free format text:ORIGINAL CODE: 0009261 | |
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT | |
| 26N | No opposition filed | Effective date:20070914 | |
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] | Ref country code:GR Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date:20070314 | |
| REG | Reference to a national code | Ref country code:CH Ref legal event code:PFA Owner name:OSMOTICA CORP. Free format text:OSMOTICA CORP.#P.O. BOX 915, R.G. HODGE PLAZA, SECOND FLOOR, UPPER MAIN STREET,#ROAD TOWN, TORTOLA (VG) -TRANSFER TO- OSMOTICA CORP.#P.O. BOX 915, R.G. HODGE PLAZA, SECOND FLOOR, UPPER MAIN STREET,#ROAD TOWN, TORTOLA (VG) | |
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] | Ref country code:LU Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date:20070108 Ref country code:CY Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date:20061213 | |
| REG | Reference to a national code | Ref country code:GB Ref legal event code:732E Free format text:REGISTERED BETWEEN 20101104 AND 20101110 | |
| REG | Reference to a national code | Ref country code:CH Ref legal event code:PUE Owner name:OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT Free format text:OSMOTICA CORP.#P.O. BOX 915, R.G. HODGE PLAZA, SECOND FLOOR, UPPER MAIN STREET,#ROAD TOWN, TORTOLA (VG) -TRANSFER TO- OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT#TOELGYFA UTCA 24 IV/B#1027 BUDAPEST (HU) Ref country code:PT Ref legal event code:PC4A Owner name:OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT, HU Effective date:20110118 | |
| REG | Reference to a national code | Ref country code:FR Ref legal event code:TP | |
| REG | Reference to a national code | Ref country code:NL Ref legal event code:SD Effective date:20110421 | |
| REG | Reference to a national code | Ref country code:ES Ref legal event code:PC2A Owner name:OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT Effective date:20110420 | |
| REG | Reference to a national code | Ref country code:CH Ref legal event code:PCOW Free format text:NEW ADDRESS: BERLINI UT 47-49, 1045 BUDAPEST (HU) | |
| REG | Reference to a national code | Ref country code:FR Ref legal event code:CA Effective date:20130930 | |
| REG | Reference to a national code | Ref country code:CH Ref legal event code:PCAR Free format text:NEW ADDRESS: HOLBEINSTRASSE 36-38, 4051 BASEL (CH) | |
| REG | Reference to a national code | Ref country code:FR Ref legal event code:PLFP Year of fee payment:16 | |
| REG | Reference to a national code | Ref country code:FR Ref legal event code:PLFP Year of fee payment:17 | |
| REG | Reference to a national code | Ref country code:FR Ref legal event code:PLFP Year of fee payment:18 | |
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] | Ref country code:FR Payment date:20191216 Year of fee payment:20 Ref country code:BE Payment date:20191217 Year of fee payment:20 | |
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] | Ref country code:FI Payment date:20200109 Year of fee payment:20 Ref country code:IT Payment date:20200114 Year of fee payment:20 Ref country code:IE Payment date:20200109 Year of fee payment:20 Ref country code:DE Payment date:20191224 Year of fee payment:20 Ref country code:AT Payment date:20191227 Year of fee payment:20 Ref country code:SE Payment date:20200110 Year of fee payment:20 Ref country code:ES Payment date:20200203 Year of fee payment:20 Ref country code:DK Payment date:20200110 Year of fee payment:20 Ref country code:NL Payment date:20200130 Year of fee payment:20 Ref country code:GB Payment date:20200102 Year of fee payment:20 Ref country code:PT Payment date:20200102 Year of fee payment:20 | |
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] | Ref country code:CH Payment date:20200116 Year of fee payment:20 | |
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] | Ref country code:TR Payment date:20200108 Year of fee payment:20 | |
| REG | Reference to a national code | Ref country code:DE Ref legal event code:R081 Ref document number:60125142 Country of ref document:DE Owner name:OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT, HU Free format text:FORMER OWNER: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT, BUDAPEST, HU Ref country code:DE Ref legal event code:R082 Ref document number:60125142 Country of ref document:DE Representative=s name:DOMPATENT VON KREISLER SELTING WERNER - PARTNE, DE | |
| REG | Reference to a national code | Ref country code:DE Ref legal event code:R071 Ref document number:60125142 Country of ref document:DE | |
| REG | Reference to a national code | Ref country code:DK Ref legal event code:EUP Expiry date:20210108 | |
| REG | Reference to a national code | Ref country code:NL Ref legal event code:MK Effective date:20210107 | |
| REG | Reference to a national code | Ref country code:CH Ref legal event code:PL | |
| REG | Reference to a national code | Ref country code:GB Ref legal event code:PE20 Expiry date:20210107 | |
| REG | Reference to a national code | Ref country code:AT Ref legal event code:MK07 Ref document number:347881 Country of ref document:AT Kind code of ref document:T Effective date:20210108 | |
| REG | Reference to a national code | Ref country code:FI Ref legal event code:MAE | |
| REG | Reference to a national code | Ref country code:SE Ref legal event code:EUG | |
| REG | Reference to a national code | Ref country code:IE Ref legal event code:MK9A | |
| REG | Reference to a national code | Ref country code:BE Ref legal event code:MK Effective date:20210108 | |
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] | Ref country code:GB Free format text:LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date:20210107 Ref country code:PT Free format text:LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date:20210120 Ref country code:IE Free format text:LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date:20210108 | |
| REG | Reference to a national code | Ref country code:ES Ref legal event code:FD2A Effective date:20220128 | |
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] | Ref country code:ES Free format text:LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date:20210109 |